Share Price and Basic Stock Data
Last Updated: October 10, 2025, 1:53 am
PEG Ratio | -1.16 |
---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Moongipa Capital Finance Ltd operates within the non-banking financial company (NBFC) sector, focusing primarily on providing financial services. The company reported a market capitalization of ₹17.2 Cr and a price of ₹18.8 per share. In recent quarters, Moongipa’s revenue has displayed significant volatility, with sales recorded at ₹0.73 Cr in June 2022, declining to ₹0.27 Cr in March 2023, before surging to ₹2.76 Cr by December 2023. This upward trend continued into March 2024, with sales reaching ₹3.02 Cr. However, there was a decline to ₹2.32 Cr in September 2024, indicating potential seasonality or market fluctuations impacting revenue. The company’s operating profit margin (OPM) stood at a healthy 43.87%, reflecting robust operational efficiency despite the fluctuating sales figures. Overall, Moongipa’s revenue trajectory suggests a recovery phase, albeit with underlying risks from inconsistent quarterly performances.
Profitability and Efficiency Metrics
Moongipa Capital Finance’s profitability metrics indicate a mixed performance over the reporting periods. The company recorded a net profit of ₹1.38 Cr, translating to an earnings per share (EPS) of ₹3.01 for March 2025. The return on equity (ROE) was reported at 9.43%, while the return on capital employed (ROCE) stood at 12.1%. The interest coverage ratio (ICR) is notably strong at 29.54x, suggesting that the company is comfortably positioned to meet its interest obligations. However, the cash conversion cycle (CCC) was recorded at 481.53 days, which is considerably high and indicates potential inefficiencies in managing receivables and inventory. This prolonged cycle could strain liquidity and impact cash flow management. In terms of operating profit, the OPM percentage for the latest quarter was 43.87%, reflecting efficiency in managing operational costs and generating profits from sales.
Balance Sheet Strength and Financial Ratios
Moongipa Capital Finance’s balance sheet reveals a cautious financial footing, with total assets amounting to ₹30.54 Cr and total liabilities of ₹6.60 Cr, resulting in a debt-to-equity ratio of 0.30. This low leverage suggests that the company is not overly reliant on debt for financing, which is a positive indicator for financial stability. The company’s reserves have significantly increased to ₹13.70 Cr as of March 2025, providing a buffer against potential financial stress. The current ratio stands at 4.29, highlighting strong liquidity, while the quick ratio is reported at 3.29, indicating that the company can easily meet short-term obligations. However, the price-to-book value (P/BV) ratio is at 0.77x, suggesting that the stock may be undervalued relative to its book value, providing a potential opportunity for investors if market conditions improve. Overall, the balance sheet metrics indicate a solid foundation, though the high CCC could pose challenges.
Shareholding Pattern and Investor Confidence
The shareholding structure of Moongipa Capital Finance Ltd reflects a stable distribution, with promoters holding 37.39% and the public owning 62.61% of the shares. The number of shareholders has increased to 5,842 as of June 2025, indicating growing investor interest and confidence in the company. Notably, there is no reported foreign institutional investment (FII) or domestic institutional investment (DII), which may suggest that institutional investors are currently wary of the company’s performance volatility. The sustained promoter shareholding over recent periods indicates confidence from the management in the company’s long-term prospects. However, the absence of institutional backing could limit the stock’s liquidity and market perception. Overall, the shareholding pattern signals a predominantly retail investor base, which could influence price stability in times of market fluctuations.
Outlook, Risks, and Final Insight
If margins sustain at current levels and the company effectively manages its cash conversion cycle, Moongipa Capital Finance could see improved profitability moving forward. However, risks remain, particularly due to the high variability in quarterly revenue and the lack of institutional support. The company must address operational efficiencies to reduce the cash conversion cycle, which currently stands at 481.53 days, to enhance liquidity and free up capital for growth initiatives. Additionally, market conditions and competitive pressures within the NBFC sector could impact performance. If management can navigate these challenges while leveraging their strong balance sheet and operational efficiencies, Moongipa may position itself as a more attractive investment in the financial services landscape. The focus should remain on enhancing shareholder value and improving financial metrics to foster greater investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Moongipa Capital Finance Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Minolta Finance Ltd | 14.1 Cr. | 1.41 | 1.91/0.84 | 94.0 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 |
Money Masters Leasing & Finance Ltd | 12.1 Cr. | 1.21 | 15.6/1.06 | 19.0 | 1.31 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
Moneyboxx Finance Ltd | 578 Cr. | 177 | 285/130 | 79.8 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
Moongipa Capital Finance Ltd | 17.7 Cr. | 19.3 | 41.0/17.5 | 13.3 | 24.9 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
Morarka Finance Ltd | 44.6 Cr. | 99.1 | 181/90.0 | 34.6 | 212 | 1.01 % | 2.46 % | 2.17 % | 10.0 |
Industry Average | 31,244.63 Cr | 490.95 | 104.29 | 498.62 | 0.21% | 15.86% | 8.84% | 8.48 |
Quarterly Result
Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 0.73 | 0.45 | 0.60 | 0.27 | 1.04 | 2.62 | 2.76 | 3.02 | 3.31 | 2.32 | 2.16 | 1.10 | 3.10 |
Expenses | 2.69 | 0.16 | 0.52 | 1.02 | 0.58 | 1.98 | 2.07 | 3.17 | 2.05 | 1.72 | 1.79 | 1.44 | 1.74 |
Operating Profit | -1.96 | 0.29 | 0.08 | -0.75 | 0.46 | 0.64 | 0.69 | -0.15 | 1.26 | 0.60 | 0.37 | -0.34 | 1.36 |
OPM % | -268.49% | 64.44% | 13.33% | -277.78% | 44.23% | 24.43% | 25.00% | -4.97% | 38.07% | 25.86% | 17.13% | -30.91% | 43.87% |
Other Income | 0.02 | 0.00 | 0.03 | 0.12 | 0.08 | 0.12 | 0.06 | 0.11 | 0.06 | 0.10 | 0.07 | 0.11 | 0.05 |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.17 |
Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
Profit before tax | -1.96 | 0.27 | 0.09 | -0.65 | 0.53 | 0.74 | 0.73 | -0.06 | 1.31 | 0.69 | 0.43 | -0.31 | 1.22 |
Tax % | -38.78% | 14.81% | 11.11% | -4.62% | 9.43% | 12.16% | 19.18% | -133.33% | 22.90% | 18.84% | 18.60% | 70.97% | 22.95% |
Net Profit | -1.21 | 0.22 | 0.08 | -0.62 | 0.48 | 0.65 | 0.59 | 0.02 | 1.01 | 0.56 | 0.35 | -0.53 | 0.95 |
EPS in Rs | -1.32 | 0.24 | 0.09 | -0.67 | 0.52 | 0.71 | 0.64 | 0.02 | 1.10 | 0.61 | 0.38 | -0.58 | 1.04 |
Last Updated: August 19, 2025, 1:00 pm
Below is a detailed analysis of the quarterly data for Moongipa Capital Finance Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 3.10 Cr.. The value appears strong and on an upward trend. It has increased from 1.10 Cr. (Mar 2025) to 3.10 Cr., marking an increase of 2.00 Cr..
- For Expenses, as of Jun 2025, the value is 1.74 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.44 Cr. (Mar 2025) to 1.74 Cr., marking an increase of 0.30 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.36 Cr.. The value appears strong and on an upward trend. It has increased from -0.34 Cr. (Mar 2025) to 1.36 Cr., marking an increase of 1.70 Cr..
- For OPM %, as of Jun 2025, the value is 43.87%. The value appears strong and on an upward trend. It has increased from -30.91% (Mar 2025) to 43.87%, marking an increase of 74.78%.
- For Other Income, as of Jun 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.11 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.06 Cr..
- For Interest, as of Jun 2025, the value is 0.17 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.07 Cr. (Mar 2025) to 0.17 Cr., marking an increase of 0.10 Cr..
- For Depreciation, as of Jun 2025, the value is 0.02 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.01 Cr. (Mar 2025) to 0.02 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.22 Cr.. The value appears strong and on an upward trend. It has increased from -0.31 Cr. (Mar 2025) to 1.22 Cr., marking an increase of 1.53 Cr..
- For Tax %, as of Jun 2025, the value is 22.95%. The value appears to be improving (decreasing) as expected. It has decreased from 70.97% (Mar 2025) to 22.95%, marking a decrease of 48.02%.
- For Net Profit, as of Jun 2025, the value is 0.95 Cr.. The value appears strong and on an upward trend. It has increased from -0.53 Cr. (Mar 2025) to 0.95 Cr., marking an increase of 1.48 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.04. The value appears strong and on an upward trend. It has increased from -0.58 (Mar 2025) to 1.04, marking an increase of 1.62.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: September 18, 2025, 2:12 am
Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 0.54 | 0.66 | 0.64 | 1.11 | 1.06 | 0.88 | 0.59 | 1.24 | 3.70 | 1.83 | 9.25 | 8.78 | 8.68 |
Expenses | 0.53 | 0.57 | 0.78 | 0.65 | 0.56 | 1.55 | 1.16 | 0.42 | 0.61 | 4.14 | 7.61 | 6.85 | 6.69 |
Operating Profit | 0.01 | 0.09 | -0.14 | 0.46 | 0.50 | -0.67 | -0.57 | 0.82 | 3.09 | -2.31 | 1.64 | 1.93 | 1.99 |
OPM % | 1.85% | 13.64% | -21.88% | 41.44% | 47.17% | -76.14% | -96.61% | 66.13% | 83.51% | -126.23% | 17.73% | 21.98% | 22.93% |
Other Income | 0.00 | 0.00 | 0.00 | 0.36 | 0.00 | 0.00 | 0.01 | 0.03 | 0.00 | 0.15 | 0.37 | 0.31 | 0.33 |
Interest | 0.03 | 0.02 | 0.00 | 0.00 | 0.03 | 0.04 | 0.02 | 0.01 | 0.00 | 0.01 | 0.00 | 0.08 | 0.24 |
Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.07 | 0.08 | 0.06 | 0.05 | 0.05 |
Profit before tax | -0.04 | 0.05 | -0.16 | 0.80 | 0.45 | -0.72 | -0.60 | 0.82 | 3.02 | -2.25 | 1.95 | 2.11 | 2.03 |
Tax % | 25.00% | 60.00% | 0.00% | 10.00% | 20.00% | -22.22% | 0.00% | 48.78% | 18.87% | -32.89% | 10.26% | 35.07% | |
Net Profit | -0.05 | 0.02 | -0.16 | 0.71 | 0.36 | -0.55 | -0.60 | 0.42 | 2.45 | -1.52 | 1.75 | 1.38 | 1.33 |
EPS in Rs | -0.05 | 0.02 | -0.17 | 0.77 | 0.39 | -0.60 | -0.65 | 0.46 | 2.66 | -1.65 | 1.90 | 1.51 | 1.45 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 140.00% | -900.00% | 543.75% | -49.30% | -252.78% | -9.09% | 170.00% | 483.33% | -162.04% | 215.13% | -21.14% |
Change in YoY Net Profit Growth (%) | 0.00% | -1040.00% | 1443.75% | -593.05% | -203.48% | 243.69% | 179.09% | 313.33% | -645.37% | 377.17% | -236.27% |
Moongipa Capital Finance Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 30% |
5 Years: | 72% |
3 Years: | 33% |
TTM: | -26% |
Compounded Profit Growth | |
---|---|
10 Years: | 53% |
5 Years: | 34% |
3 Years: | -17% |
TTM: | -41% |
Stock Price CAGR | |
---|---|
10 Years: | 15% |
5 Years: | 62% |
3 Years: | 9% |
1 Year: | -42% |
Return on Equity | |
---|---|
10 Years: | 8% |
5 Years: | 13% |
3 Years: | 6% |
Last Year: | 9% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: September 10, 2025, 3:58 pm
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 9.16 |
Reserves | 0.50 | 0.51 | 0.35 | 1.06 | 1.42 | 0.87 | 0.26 | 0.68 | 3.13 | 1.61 | 3.35 | 13.70 |
Borrowings | 0.26 | 0.05 | 0.40 | 0.25 | 0.61 | 0.31 | 0.31 | 0.00 | 0.00 | 0.12 | 0.00 | 7.01 |
Other Liabilities | 0.04 | 0.03 | 0.02 | 0.08 | 0.03 | 0.06 | 0.05 | 0.21 | 0.78 | 0.06 | 0.20 | 0.67 |
Total Liabilities | 3.85 | 3.64 | 3.82 | 4.44 | 5.11 | 4.29 | 3.67 | 3.94 | 6.96 | 4.84 | 6.60 | 30.54 |
Fixed Assets | 0.07 | 0.04 | 0.07 | 0.05 | 0.04 | 0.03 | 0.07 | 0.05 | 0.31 | 0.23 | 0.18 | 0.13 |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.88 | 0.93 | 1.33 | 1.47 | 1.65 | 0.96 | 1.60 | 2.58 | 5.34 | 2.64 | 1.43 | 6.85 |
Other Assets | 2.90 | 2.67 | 2.42 | 2.92 | 3.42 | 3.30 | 2.00 | 1.31 | 1.31 | 1.97 | 4.99 | 23.56 |
Total Assets | 3.85 | 3.64 | 3.82 | 4.44 | 5.11 | 4.29 | 3.67 | 3.94 | 6.96 | 4.84 | 6.60 | 30.54 |
Below is a detailed analysis of the balance sheet data for Moongipa Capital Finance Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 9.16 Cr.. The value appears strong and on an upward trend. It has increased from 3.05 Cr. (Mar 2024) to 9.16 Cr., marking an increase of 6.11 Cr..
- For Reserves, as of Mar 2025, the value is 13.70 Cr.. The value appears strong and on an upward trend. It has increased from 3.35 Cr. (Mar 2024) to 13.70 Cr., marking an increase of 10.35 Cr..
- For Borrowings, as of Mar 2025, the value is 7.01 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2024) to 7.01 Cr., marking an increase of 7.01 Cr..
- For Other Liabilities, as of Mar 2025, the value is 0.67 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.20 Cr. (Mar 2024) to 0.67 Cr., marking an increase of 0.47 Cr..
- For Total Liabilities, as of Mar 2025, the value is 30.54 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.60 Cr. (Mar 2024) to 30.54 Cr., marking an increase of 23.94 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.13 Cr.. The value appears to be declining and may need further review. It has decreased from 0.18 Cr. (Mar 2024) to 0.13 Cr., marking a decrease of 0.05 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 6.85 Cr.. The value appears strong and on an upward trend. It has increased from 1.43 Cr. (Mar 2024) to 6.85 Cr., marking an increase of 5.42 Cr..
- For Other Assets, as of Mar 2025, the value is 23.56 Cr.. The value appears strong and on an upward trend. It has increased from 4.99 Cr. (Mar 2024) to 23.56 Cr., marking an increase of 18.57 Cr..
- For Total Assets, as of Mar 2025, the value is 30.54 Cr.. The value appears strong and on an upward trend. It has increased from 6.60 Cr. (Mar 2024) to 30.54 Cr., marking an increase of 23.94 Cr..
Notably, the Reserves (13.70 Cr.) exceed the Borrowings (7.01 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -0.25 | 0.04 | -0.54 | 0.21 | -0.11 | -0.98 | -0.88 | 0.82 | 3.09 | -2.43 | 1.64 | -5.08 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 1,013.89 | 1,249.85 | 216.72 | 85.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.96 | 7.10 | 50.72 |
Inventory Days | 463.06 | 199.54 | 430.81 | |||||||||
Days Payable | 0.00 | 0.00 | 0.00 | |||||||||
Cash Conversion Cycle | 1,013.89 | 1,249.85 | 216.72 | 85.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 477.02 | 206.64 | 481.53 |
Working Capital Days | 919.26 | 1,227.73 | 39.92 | 62.48 | 134.29 | 825.40 | 532.03 | 158.95 | 53.27 | 295.19 | 177.96 | 875.92 |
ROCE % | -0.26% | 1.89% | -4.32% | 19.61% | 10.17% | -14.61% | -15.03% | 22.59% | 60.95% | -40.88% | 34.88% | 12.08% |
This stock is not held by any mutual fund.
Key Financial Ratios
Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 3.01 | 5.71 | -4.98 | 8.01 | 1.36 |
Diluted EPS (Rs.) | 3.01 | 5.71 | -4.98 | 8.01 | 1.36 |
Cash EPS (Rs.) | 1.56 | 5.91 | -4.71 | 8.23 | 1.43 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 24.94 | 20.97 | 15.26 | 20.23 | 12.23 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 24.94 | 20.97 | 15.26 | 20.23 | 12.23 |
Revenue From Operations / Share (Rs.) | 9.56 | 30.28 | 5.98 | 10.45 | 3.22 |
PBDIT / Share (Rs.) | 2.44 | 6.59 | -7.09 | 10.11 | 2.78 |
PBIT / Share (Rs.) | 2.39 | 6.38 | -7.36 | 9.89 | 2.71 |
PBT / Share (Rs.) | 2.30 | 6.38 | -7.39 | 9.88 | 2.68 |
Net Profit / Share (Rs.) | 1.50 | 5.71 | -4.98 | 8.01 | 1.36 |
PBDIT Margin (%) | 25.52 | 21.75 | -118.56 | 96.75 | 86.25 |
PBIT Margin (%) | 24.97 | 21.08 | -123.04 | 94.61 | 84.15 |
PBT Margin (%) | 24.10 | 21.07 | -123.44 | 94.55 | 83.13 |
Net Profit Margin (%) | 15.71 | 18.86 | -83.15 | 76.61 | 42.29 |
Return on Networth / Equity (%) | 6.02 | 27.23 | -32.61 | 39.56 | 11.14 |
Return on Capital Employeed (%) | 9.32 | 29.77 | -48.15 | 43.60 | 21.19 |
Return On Assets (%) | 4.50 | 26.44 | -31.41 | 35.12 | 10.56 |
Total Debt / Equity (X) | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover Ratio (%) | 0.47 | 1.62 | 0.30 | 0.58 | 0.25 |
Current Ratio (X) | 4.29 | 137.98 | 27.37 | 189.17 | 118.77 |
Quick Ratio (X) | 3.29 | 59.81 | 22.32 | 189.17 | 118.77 |
Interest Coverage Ratio (X) | 29.54 | 1770.36 | -298.50 | 1674.16 | 83.93 |
Interest Coverage Ratio (Post Tax) (X) | 19.19 | 1536.47 | -208.36 | 1326.56 | 42.16 |
Enterprise Value (Cr.) | 24.69 | 8.89 | 5.21 | 6.73 | 0.91 |
EV / Net Operating Revenue (X) | 2.82 | 0.96 | 2.85 | 2.11 | 0.92 |
EV / EBITDA (X) | 11.04 | 4.42 | -2.40 | 2.18 | 1.08 |
MarketCap / Net Operating Revenue (X) | 2.02 | 0.96 | 2.86 | 2.14 | 1.07 |
Price / BV (X) | 0.77 | 1.40 | 1.12 | 1.11 | 0.28 |
Price / Net Operating Revenue (X) | 2.02 | 0.96 | 2.86 | 2.14 | 1.07 |
EarningsYield | 0.07 | 0.19 | -0.29 | 0.35 | 0.39 |
After reviewing the key financial ratios for Moongipa Capital Finance Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.01. This value is below the healthy minimum of 5. It has decreased from 5.71 (Mar 24) to 3.01, marking a decrease of 2.70.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.01. This value is below the healthy minimum of 5. It has decreased from 5.71 (Mar 24) to 3.01, marking a decrease of 2.70.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 3. It has decreased from 5.91 (Mar 24) to 1.56, marking a decrease of 4.35.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.94. It has increased from 20.97 (Mar 24) to 24.94, marking an increase of 3.97.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.94. It has increased from 20.97 (Mar 24) to 24.94, marking an increase of 3.97.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 9.56. It has decreased from 30.28 (Mar 24) to 9.56, marking a decrease of 20.72.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.44. This value is within the healthy range. It has decreased from 6.59 (Mar 24) to 2.44, marking a decrease of 4.15.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 6.38 (Mar 24) to 2.39, marking a decrease of 3.99.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.30. This value is within the healthy range. It has decreased from 6.38 (Mar 24) to 2.30, marking a decrease of 4.08.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.50. This value is below the healthy minimum of 2. It has decreased from 5.71 (Mar 24) to 1.50, marking a decrease of 4.21.
- For PBDIT Margin (%), as of Mar 25, the value is 25.52. This value is within the healthy range. It has increased from 21.75 (Mar 24) to 25.52, marking an increase of 3.77.
- For PBIT Margin (%), as of Mar 25, the value is 24.97. This value exceeds the healthy maximum of 20. It has increased from 21.08 (Mar 24) to 24.97, marking an increase of 3.89.
- For PBT Margin (%), as of Mar 25, the value is 24.10. This value is within the healthy range. It has increased from 21.07 (Mar 24) to 24.10, marking an increase of 3.03.
- For Net Profit Margin (%), as of Mar 25, the value is 15.71. This value exceeds the healthy maximum of 10. It has decreased from 18.86 (Mar 24) to 15.71, marking a decrease of 3.15.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.02. This value is below the healthy minimum of 15. It has decreased from 27.23 (Mar 24) to 6.02, marking a decrease of 21.21.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.32. This value is below the healthy minimum of 10. It has decreased from 29.77 (Mar 24) to 9.32, marking a decrease of 20.45.
- For Return On Assets (%), as of Mar 25, the value is 4.50. This value is below the healthy minimum of 5. It has decreased from 26.44 (Mar 24) to 4.50, marking a decrease of 21.94.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.30. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.30, marking an increase of 0.30.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.47. It has decreased from 1.62 (Mar 24) to 0.47, marking a decrease of 1.15.
- For Current Ratio (X), as of Mar 25, the value is 4.29. This value exceeds the healthy maximum of 3. It has decreased from 137.98 (Mar 24) to 4.29, marking a decrease of 133.69.
- For Quick Ratio (X), as of Mar 25, the value is 3.29. This value exceeds the healthy maximum of 2. It has decreased from 59.81 (Mar 24) to 3.29, marking a decrease of 56.52.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 29.54. This value is within the healthy range. It has decreased from 1,770.36 (Mar 24) to 29.54, marking a decrease of 1,740.82.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 19.19. This value is within the healthy range. It has decreased from 1,536.47 (Mar 24) to 19.19, marking a decrease of 1,517.28.
- For Enterprise Value (Cr.), as of Mar 25, the value is 24.69. It has increased from 8.89 (Mar 24) to 24.69, marking an increase of 15.80.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.82. This value is within the healthy range. It has increased from 0.96 (Mar 24) to 2.82, marking an increase of 1.86.
- For EV / EBITDA (X), as of Mar 25, the value is 11.04. This value is within the healthy range. It has increased from 4.42 (Mar 24) to 11.04, marking an increase of 6.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has increased from 0.96 (Mar 24) to 2.02, marking an increase of 1.06.
- For Price / BV (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has decreased from 1.40 (Mar 24) to 0.77, marking a decrease of 0.63.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has increased from 0.96 (Mar 24) to 2.02, marking an increase of 1.06.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has decreased from 0.19 (Mar 24) to 0.07, marking a decrease of 0.12.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Moongipa Capital Finance Ltd:
- Net Profit Margin: 15.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.32% (Industry Average ROCE: 15.86%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.02% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 19.19
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.29
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.3 (Industry average Stock P/E: 104.29)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.3
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 15.71%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Non-Banking Financial Company (NBFC) | 18/14, W.E.A. Pusa Lane, Karol Bagh, New Delhi Delhi 110005 | moongipac@gmail.com http://www.mongipa.com |
Management | |
---|---|
Name | Position Held |
Dr.(Ms.) Pooja Jain | Whole Time Director |
Mr. Sanjay Jain | Non Executive Director |
Mr. Ajay Prakash Narain | Independent Director |
Mr. Rajesh Kumar | Independent Director |
FAQ
What is the intrinsic value of Moongipa Capital Finance Ltd?
Moongipa Capital Finance Ltd's intrinsic value (as of 09 October 2025) is 25.48 which is 32.02% higher the current market price of 19.30, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹17.7 Cr. market cap, FY2025-2026 high/low of 41.0/17.5, reserves of ₹13.70 Cr, and liabilities of 30.54 Cr.
What is the Market Cap of Moongipa Capital Finance Ltd?
The Market Cap of Moongipa Capital Finance Ltd is 17.7 Cr..
What is the current Stock Price of Moongipa Capital Finance Ltd as on 09 October 2025?
The current stock price of Moongipa Capital Finance Ltd as on 09 October 2025 is 19.3.
What is the High / Low of Moongipa Capital Finance Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Moongipa Capital Finance Ltd stocks is 41.0/17.5.
What is the Stock P/E of Moongipa Capital Finance Ltd?
The Stock P/E of Moongipa Capital Finance Ltd is 13.3.
What is the Book Value of Moongipa Capital Finance Ltd?
The Book Value of Moongipa Capital Finance Ltd is 24.9.
What is the Dividend Yield of Moongipa Capital Finance Ltd?
The Dividend Yield of Moongipa Capital Finance Ltd is 0.00 %.
What is the ROCE of Moongipa Capital Finance Ltd?
The ROCE of Moongipa Capital Finance Ltd is 12.1 %.
What is the ROE of Moongipa Capital Finance Ltd?
The ROE of Moongipa Capital Finance Ltd is 9.43 %.
What is the Face Value of Moongipa Capital Finance Ltd?
The Face Value of Moongipa Capital Finance Ltd is 10.0.